2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$49.56-$0.94 (-1.85%)
Price as of Oct 22, 2026 7:56 PM EDT- $5.0BMarket Cap
- -24.08%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$49.56-$0.94 (-1.85%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ARK INVESTMENT MANAGEMENT LLC | 9.78% | 9.5M | -1.9M (-19.58%) | Jun 30, 2026 |
BLACKROCK, INC. | 8.63% | 8.3M | +668,904 (+8.01%) | Jun 30, 2026 |
ORBIS ALLAN GRAY LTD | 5.64% | 5.4M | -656,850 (-12.05%) | Jun 30, 2026 |
CAPITAL WORLD INVESTORS | 4.91% | 4.7M | +24,488 (+0.52%) | Jun 30, 2026 |
STATE STREET CORP | 4.47% | 4.3M | +339,166 (+7.85%) | Jun 30, 2026 |
GSK PLC | 3.33% | 3.2M | 0 (0.00%) | Jun 30, 2026 |
BLACKROCK INC. | 2.87% | 2.8M | +231,423 (+8.33%) | Jun 30, 2024 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 1.14% | 1.1M | +34,368 (+3.11%) | Jun 30, 2026 |
T. Rowe Price Mid-Cap Growth Fund, Inc. | 1.09% | 1.1M | -20.4M (-1,938.47%) | Jun 30, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.57% | 548,961 | +45,937 (+8.37%) | May 31, 2026 |
Morningstar Funds Trust | 0.41% | 394,000 | 0 (0.00%) | Jul 31, 2026 |
GuideStone Funds | 0.40% | 386,000 | -451,000 (-116.84%) | Jun 30, 2026 |
TIAA-CREF FUNDS | 0.20% | 188,836 | +12,323 (+6.53%) | Jul 31, 2026 |
AMERICAN CENTURY ETF TRUST | 0.13% | 125,132 | +7,499 (+5.99%) | May 31, 2026 |
Current Ownership Distribution
- Institutions1.2B (87.64%)
- Mutual Funds142.4M (10.68%)
- Insiders22.4M (1.68%)
- Other0 (0.00%)
Insider Transactions
- 1.68% (22.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $111.2MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Kulkarni Samarth Chief Executive Officer | Sell | Oct 19, 2026 | $2.4M | 47,837 | $49.78 | 311,899 |
Kulkarni Samarth Chief Executive Officer | Exempt | Oct 16, 2026 | $0.00 | 100,000 | $0.00 | 200,000 |
Kulkarni Samarth Chief Executive Officer | Exempt | Oct 16, 2026 | $0.00 | 100,000 | $0.00 | 359,736 |
Kulkarni Samarth Chief Executive Officer | Sell | Oct 14, 2026 | $201,867.48 | 4,098 | $49.26 | 259,736 |
KASINGER JAMES R. General Counsel and Secretary | Sell | Oct 14, 2026 | $51,230.40 | 1,040 | $49.26 | 95,857 |
Kulkarni Samarth Chief Executive Officer | Exempt | Oct 13, 2026 | $0.00 | 8,333 | $0.00 | 0 |
KASINGER JAMES R. General Counsel and Secretary | Exempt | Oct 13, 2026 | $0.00 | 2,113 | $0.00 | 0 |
Kulkarni Samarth Chief Executive Officer | Exempt | Oct 13, 2026 | $0.00 | 8,333 | $0.00 | 263,834 |
KASINGER JAMES R. General Counsel and Secretary | Exempt | Oct 13, 2026 | $0.00 | 2,113 | $0.00 | 96,897 |
KASINGER JAMES R. General Counsel and Secretary | Exempt | Sep 22, 2026 | $0.00 | 10,400 | $0.00 | 83,232 |
KASINGER JAMES R. General Counsel and Secretary | Exempt | Sep 22, 2026 | $141,648.00 | 10,400 | $13.62 | 105,184 |
KASINGER JAMES R. General Counsel and Secretary | Sell | Sep 22, 2026 | $626,459.60 | 10,400 | $60.24 | 94,784 |
Behbahani Ali | Exempt | Sep 17, 2026 | $0.00 | 30,000 | $0.00 | 0 |
Behbahani Ali | Exempt | Sep 17, 2026 | $420,000.00 | 30,000 | $14.00 | 30,316 |
Behbahani Ali | Sell | Sep 17, 2026 | $780,935.48 | 13,679 | $57.09 | 16,637 |
Prasad Raju Chief Financial Officer | Gift | Aug 07, 2026 | $0.00 | 750 | $0.00 | 14,815 |
Kulkarni Samarth Chief Executive Officer | Sell | Mar 23, 2026 | $468,735.60 | 10,020 | $46.78 | 255,501 |
Kulkarni Samarth Chief Executive Officer | Award | Mar 20, 2026 | $0.00 | 114,249 | $0.00 | 114,249 |
Kulkarni Samarth Chief Executive Officer | Award | Mar 20, 2026 | $0.00 | 81,875 | $0.00 | 81,875 |
Kulkarni Samarth Chief Executive Officer | Exempt | Mar 20, 2026 | $0.00 | 19,687 | $0.00 | 39,375 |
Kulkarni Samarth Chief Executive Officer | Exempt | Mar 20, 2026 | $0.00 | 19,687 | $0.00 | 265,521 |
KASINGER JAMES R. General Counsel and Secretary | Sell | Mar 16, 2026 | $166,497.00 | 3,450 | $48.26 | 91,240 |
Patel Naimish Chief Medical Officer | Sell | Mar 16, 2026 | $152,019.00 | 3,150 | $48.26 | 13,143 |
Prasad Raju Chief Financial Officer | Sell | Mar 16, 2026 | $282,224.48 | 5,848 | $48.26 | 17,794 |
Kulkarni Samarth Chief Executive Officer | Sell | Mar 16, 2026 | $499,442.74 | 10,349 | $48.26 | 245,834 |
Prasad Raju Chief Financial Officer | Sell | Mar 16, 2026 | $194,053.46 | 4,021 | $48.26 | 13,773 |
Prasad Raju Chief Financial Officer | Gift | Mar 16, 2026 | $0.00 | 750 | $0.00 | 13,023 |
KASINGER JAMES R. General Counsel and Secretary | Exempt | Mar 14, 2026 | $0.00 | 6,875 | $0.00 | 20,625 |
Patel Naimish Chief Medical Officer | Exempt | Mar 14, 2026 | $0.00 | 8,125 | $0.00 | 24,375 |
KASINGER JAMES R. General Counsel and Secretary | Exempt | Mar 14, 2026 | $0.00 | 6,875 | $0.00 | 94,690 |